Table 1.
Nanocellulose | CD | Functionalisation Strategy | Application | Source |
---|---|---|---|---|
toCNFs | βCD | Direct grafting | Release of essential oil | [48] |
CNFs | βCD | Cross-linking with citric acid | Depollution | [49] |
toCNFs | CMβCD | Amidation via EDC/NHS | Depollution | [50] |
HP-CNFs | HPβCD | Electrospinning | Drug release | [51] |
CNFs | βCD | Coating/Adsorption | Drug release | [52] |
CNFs | βCD | Cross-linking with citric acid | Antibacterial packaging | [53] |
toCNF | βCD | Noncovalent interaction | Drug Delivery/ Tissue Engineering | [29] |
toCNCs | βCD/HPβCD | Direct grafting | Release of essential oil | [54] |
CNCs | βCD | Grafting with epichlorohydrin | Tissue engineering | [55] |
CNCs | βCD | Crosslinking with fumaric and succinic acid | Release of essential oil | [56] |
CNCs | βCD | Ionic interaction | Drug delivery | [57] |
CNCs | βCD | Grafting with epichlorohydrin | Supramolecular hydrogels | [58] |